NCT06479382View on ClinicalTrials.gov

Study of the ETX-4143 2.0 Device in Subjects With Eye Pain

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

November 29, 2024

Study Completion Date

November 29, 2024

Conditions
Eye Pain
Interventions
DEVICE

ETX-4143 2.0

Treatment of the eye with the ETX-4143 2.0 device

Trial Locations (4)

2145

Westmead Hospital, Westmead

3021

Sunshine Eye Surgeons, St Albans

4005

Ophthamic Trials Australia, Brisbane

5000

Innovative Eye Care, Adelaide

Sponsors
All Listed Sponsors
lead

EyeCool Therapeutics, Inc.

INDUSTRY

NCT06479382 - Study of the ETX-4143 2.0 Device in Subjects With Eye Pain | Biotech Hunter | Biotech Hunter